| Women | Men | |
| Segmental basis | ||
| Interpretable | 728/762 (96, 95 to 97) | 704/723 (97, 96 to 98) |
| Sensitivity | 41/48 (85, 75 to 95) | 81/95 (85, 78 to 92) |
| Specificity | 673/680 (99, 98 to 100) | 603/609 (99, 98 to 100) |
| PPV | 41/48 (85, 75 to 95) | 81/87 (93, 88 to 98) |
| NPV | 673/680 (99, 98 to 100) | 603/617 (98, 97 to 99) |
| Positive LR (LR, 95% CI) | 82.98 (39.34 to 174.99) | 86.54 (38.86 to 192.72) |
| Negative LR (LR, 95% CI) | 0.15 (0.07 to 0.29) | 0.15 (0.09 to 0.24) |
| Diagnostic OR (OR, 95% CI) | 563.12 (191.21 to 1659.22) | 581.46 (220.59 to 1524.5) |
| Vessel basis | ||
| Interpretable | 200/208 (96, 93 to 99) | 200/204 (98, 96 to 100) |
| Sensitivity | 34/37 (92, 83 to 100) | 56/63 (89, 81 to 97) |
| Specificity | 158/163 (97, 94 to 100) | 132/137 (96, 93 to 99) |
| PPV | 34/39 (87, 76 to 98) | 56/61 (92, 85 to 99) |
| NPV | 158/161 (98, 96 to 100) | 132/139 (95, 91 to 99) |
| Positive LR (LR, 95% CI) | 29.96 (12.57 to 71.38) | 24.36 (10.26 to 57.83) |
| Negative LR (LR, 95% CI) | 0.08 (0.03 to 0.25) | 0.12 (0.06 to 0.23) |
| Diagnostic OR (OR, 95% CI) | 358.13 (84.76 to 1494.5) | 211.2 (65.48 to 679.41) |
| Patient basis | ||
| Interpretable | 50/52 (96, 91 to 100) | 50/51 (98, 94 to 100) |
| Sensitivity | 21/22 (95, 87 to 100) | 32/32 (100, NA) |
| Specificity | 26/28 (93, 83 to 100) | 16/18 (89, 74 to 100) |
| PPV | 21/23 (91, 79 to 100) | 32/34 (94, 86 to 100) |
| NPV | 26/27 (96, 89 to 100) | 16/16 (100, NA) |
| Positive LR (LR, 95% CI) | 13.36 (3.50 to 50.97) | 9 (2.44 to 33.24) |
| Negative LR (LR, 95% CI) | 0.05 (0.01 to 0.33) | 0 (0 to 0.09) |
| Diagnostic OR (OR, 95% CI) | 273 (27.14 to 2464.86) | NA |
Data are absolute values used to calculate percentages unless otherwise indicated. Data in parentheses are the percentages with 95% confidence intervals unless otherwise indicated.
CI, confidence intervals; LR, likelihood ratio; MSCT, multislice computed tomography; NA, not applicable; NPV, negative predictive value; OR, odds ratio; PPV, positive predictive value.